The investment is in a pharmaceutical and medical device component manufacturing facility in Suzhou, China, near Shanghai
The US$ 15 million Tekni-Plex investment reflects the growing needs of the Asia-Pacific pharmaceutical and medical device market. Production for some product lines have already begun.
Initially the 13000m2 facility will manufacture products for Tekni-Plex’s Natvar, Colorite and Action Technology business units.
The facility will feature three ISO Class 8 (100K) cleanrooms to accommodate medical grade tubing and components production and one ISO Class 7 (10K) cleanroom that will produce Natvar’s pharma grade tubing.
The facility will also produce Natvar’s recently announced silicone extrusion tubing for catheters, feeding tubes, drug delivery and peristaltic pump applications, as well as microextrusion tubing that targets a wide variety of demanding neurovascular interventional therapies and surgical applications.
The facility will also manufacture Colorite custom compounds for medical device applications, and Action Technology’s dip tubes used in a wide variety of food/beverage, pharmaceutical, personal care, industrial and household pump applications.
Paul Young, CEO at Tekni Plex, said: “Tekni-Plex’s investment in our new China facility is another step in our continuing commitment to support our customers with robust global supply. Pharmaceutical, medical device and other manufacturers want access to exactly the same components and materials regardless of where in the world their manufacturing facility is located. It is our goal to meet those objectives.”
Tekni-Plex is in the process of phasing out production at its existing facility in Suzhou that it has operated since 2005.